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Abstract
Background: The transmembrane presenilin (PSEN) proteins, PSEN1 and PSEN2, have been
proposed to be the catalytic components of the γ-secretase protein complex, which is an
intramembranous multimeric protease involved in development, cell regulatory processes, and
neurodegeneration in Alzheimer's disease. Here we describe the sequencing, chromosomal
mapping, and polymorphism analysis of PSEN1 and PSEN2 in the domestic pig (Sus scrofa
domesticus).
Conclusion: The data provide evidence for structural and functional conservation of PSENs in
mammalian lineages, and may suggest that the high sequence similarity and colocalization of PSEN1
and PSEN2 in brain tissue reflect a certain degree of functional redundancy. The data show that pigs
may provide a new animal model for detailed analysis of the developmental functions of the PSENs.
Background
The transmembrane presenilin (PSEN) 1 and 2 proteins
are the catalytic subunits of the γ-secretase complex,
which mediates intramembranous proteolytic cleavage of
a number of transmembrane proteins [1,2]. In addition to
the PSEN proteins the γ-secretase complex includes PEN-
2, nicastrin and APH-1. Examples of γ-secretase processed
proteins are Notch, Jagged, CD44, LRP, NGFRd, ERBB4,
and APP. A common theme in γ-secretase mediated prote-
olytic processing is the generation of intracellular C-termi-
nal domains, which migrates to the nuclear compartment
to regulate expression of target genes. γ-secretase-inde-
pendent functions of the PSEN proteins have also been
described, including regulation of protein localization,
apoptosis, calcium homoeostasis, and Wnt signal trans-
duction [1,3]. Human PSEN1 and PSEN2 share more than
60% amino acid identity and both PSENs are processed
proteolytically to generate amino- and carboxyl-frag-
ments, which associate in the bioactive γ-secretase com-
plex [4].
The PSENs are multifunctional and have important roles
in embryonic development through regulation of cellular
signal transduction pathways. Thus, studies of PSEN1-
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perinatally and that PSEN1 is required for formation of
the axial skeleton, normal neurogenesis, and neuronal
survival [5,6]. The PSEN1 mutant phenotype can in part
be explained from experiments in mouse [7], Caenorhab-
ditis elegans [8], and Drosophila melanogaster [9], which
have demonstrated an essential role for PSENs in Notch
signalling [2,10]. PSEN2 homozygous null mutant mice
are viable, presumable due to a compensation effect of the
more abundantly expressed PSEN1. Interestingly, com-
plete loss of both PSENs causes more widespread develop-
mental defects than observed for the PSEN1 null mutant,
which suggest overlapping but not identical cellular roles
of PSEN1 and PSEN2 [11,12]. Importantly, genetic and
biochemical evidence have demonstrated that mutations
in human PSEN1 and PSEN2 play a role in the develop-
ment of familiar Alzheimer's disease by altering APP
processing to increase the ratio between the more aggrega-
tion-prone Aβ42 peptide and the Aβ40 variant [13]
Although studies of the PSENs in Caenorhabditis elegans,
Drosophila melanogaster and mice have yielded important
insight into the biological role of the PSENs, several essen-
tial questions still remain concerning the developmental
functions of PSEN1 and PSEN2. Strong anatomical, phys-
iological and biochemical similarities between man and
pig suggest that this animal may constitute a suitable alter-
native model for research related to Alzheimer's disease,
although Alzheimer-like neuropathology including Aβ
deposits in the brains of aged pigs to our knowledge has
not yet been described. To begin to address this possibil-
ity, we here present the first molecular characterization of
the porcine PSENs by sequence analysis, determination of
chromosomal localization and screening for polymor-
phisms. Moreover, the expression profiles of PSEN1 and
PSEN2 were studied both at the mRNA and protein levels
in several areas of the embryonic pig brain. The results
show a high degree of evolutionary conservation of both
the porcine primary sequences and the expression pat-
terns compared to those observed in human and rodents.
Results
PSEN1 and PSEN2 cDNA and protein sequence
To determine the cDNA sequence of porcine PSEN1, we
designed a set of primers based on the conserved 5' and 3'
untranslated regions between the rodent, bovine, and
human PSEN1. Using RT-PCR, the cDNA representing the
entire pig PSEN1 open reading frame was amplified,
cloned and sequenced. The porcine cDNA was highly
homologous (90 % identity) throughout the sequence to
human PSEN1 sequence, but only homologous to human
PSEN2 in short dispersed regions. The length of the
deduced porcine PSEN1 protein was 467 amino acids,
which is identical to the sizes of the human and mouse
counterparts (Figure 1). Multiple amino acid sequence
alignment of PSEN1 revealed 92 % sequence identity
between the pig and human proteins (Figure 1). Further-
more, 34 amino acid changes were observed between the
two sequences of which 11 were conservative substitu-
tions. Comparison of pig and mouse amino acid
sequences revealed 89% identity, and 16 out of 50 amino
acid changes were conservative. The cow PSEN1 consists
of 478 amino acids with 94 % identity to the porcine pro-
tein, and 12 out of 28 amino acid substitutions were con-
servative. Mutations in human PSEN1 cause Alzheimer's
disease and it is noteworthy that none of the amino acid
changes between pig and human are located in positions
known to cause Alzheimer's disease (Figure 1).  At posi-
tion 318 where the human PSEN1 contains a non-patho-
genic polymorphism, E318G, a Q residue is present at the
equivalent positions in pig, cow, and mouse PSEN1 [14].
Two non-pathogenic polymorphisms R35Q and F175S in
human PSEN1 are occupied by R and F in the porcine
PSEN1 (Figure 1) [15,16].
The human PSEN2 cDNA sequence was used for BLASTN
searches against NCBI databases as well as an in-house
porcine EST database [17] to identify sequences for the
design of primers corresponding to the 5'-end of the cod-
ing region and the 3'-non-coding region of the pig PSEN2.
The primers amplified a cDNA fragment of approximately
1.4 kb, which was cloned and sequenced. Analysis
revealed high nucleotide sequence homology with
human PSEN2 (92 % identity), whereas homology to the
human PSEN1 cDNA was restricted to small, dispersed
regions, which demonstrates that the cloned fragment
encodes the porcine homolog of PSEN2. Translation of
the open reading frame showed that the porcine PSEN2
protein like the human and mouse homologs consisted of
448 amino acid residues (Figure 2). Multiple amino acid
sequence alignment revealed 97.8 % sequence identity
between the pig and the human PSEN2, and 1 of the
observed 10 changes was conservative (Figure 2). Com-
parison of pig and mouse amino acid sequences showed
an identity of 95 % with 8 out of the 20 changes being
conservative. The cow PSEN2 has a length of 449 amino
acids and a sequence identity of 98.2 %, where 4 of the 8
substitutions are conservative. Thus, as observed for
PSEN1, also the porcine PSEN2 protein showed the high-
est degree of identity to the bovine counterpart. Moreover,
it should be noted that none of the observed changes
between the sequences of the different species are located
in PSEN2 positions identified as being mutated in Alzhe-
imer's disease patients (Figure 2) [18]. At position 334 a
non-pathogenic polymorphism, P334R, has been identi-
fied in human PSEN2 [15,19], and the proline residue was
conserved in the porcine protein.
The amino acid sequence for porcine PSEN1 shows 64%
identity to porcine PSEN2 and particularly amino acids inPage 2 of 11
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BMC Neuroscience 2007, 8:72 http://www.biomedcentral.com/1471-2202/8/72the transmembrane domains and the C-terminus are con-
served (data not shown). Also, the two aspartic acid resi-
dues located in transmembrane domain 6 (D257 in
PSEN1 and D263 in PSEN2) and the transmembrane
domain 7 (D385 in PSEN1 and D366 in PSEN2), as well
as the "PAL" sequence, (P433, A434, L435 in PSEN1 and
P414, A415, L416 in PSEN2) are conserved in both por-
cine PSEN1 and PSEN2, consistent with the essential role
of these residues for the protease catalytic function of the
presenilins [15,20,21].
Mapping of porcine PSEN1 and PSEN2
A porcine-rodent somatic cell hybrid panel was used for
the chromosomal mapping of porcine PSEN1 and PSEN2
genes (data not shown) [22]. Statistical evaluation by
applying the "Interpreting PCR data" program [23]
resulted in a chromosomal assignment of the PSEN1 gene
to chromosome 7q12-q26 with a probability of 0.4494
and a correlation of 1. This conclusion gains support from
the facts that the specified region of porcine chromosome
7 shares homology with the human chromosome 14, and
that the human PSEN1 gene has been mapped to
HSA14q24.3 [24]. However, the relatively low probability
value suggests that the chromosomal position of the por-
cine PSEN1 gene should be considered preliminary. The
PSEN2 gene was assigned to chromosome 10p11-p16
with a probability of 0.9959 and a correlation of 0.7255,
which is in agreement with the syntenic relationship
between porcine chromosome 10 and human chromo-
some 1, and the known position of PSEN2 on HSA1q31-
q42 [24].
Multiple amino acid sequence alignment of PSEN1Figure 1
Multiple amino acid sequence alignment of PSEN1. The alignment was performed using Clustal W. The sequences are Sus scrofa 
(DQ853416), Bos taurus (NM 174721), Homo sapiens (NM 000021), and Mus musculus (NM 008943). An asterisk (*) indicates 
amino acids conserved among the sequences, whereas amino acid discrepancies are marked in bold. Above the sequence align-
ments are by (+) indicated the position of pathogenic missense mutations identified in human PSEN1. Also the position of 
human missense SNPs are indicated above the sequence alignments with the alternative amino acids in bold. Furthermore, the 
9 transmembrane domains are depicted in cyan according to literature [32] and the transmembrane prediction programme 
HMMTOP [33]. Moreover, the amino acid residues representing the C-terminal loop are shown in yellow. The blue color rep-
resents the fragment, which has been subjected to a SNP screening in the pig.Page 3 of 11
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PSEN1
To examine for genetic variation in porcine PSEN1, we
resequenced exons 5, 7, 8, and 9 in a large animal material
consisting of 900 Landrace/Yorkshire crossbreed sows and
a pig breed panel consisting of 55 Landrace, Duroc, York-
shire and Hampshire breeds. These exons were chosen for
sequence analysis because they constitute "hotspots" for
mutations in familiar Alzheimer's disease. However, no
SNP's were identified in the 4 exonic regions (data not
shown). Next, we extended the polymorphism analysis to
include intronic sequences, which identified a C/T SNP at
position 58 in intron 8 (position 1163 in the sequence
deposited in DQ86246) as well as two C/T polymor-
phisms at positions 52 and 92 and a G/A polymorphism
at position 117 in intron 10 (positions 1535, 1575, and
1600 in the DQ86246). The genotyping data are summa-
rized in table 1 and table 2. All breeds except Hampshire
were polymorphic in intron 8 and at positions 52 and 92
in intron 10, whereas only the Yorkshire breed was poly-
morphic at position 117 in intron 10. Genotype frequen-
cies were in accordance with Hardy-Weinberg
equilibrium, indicating that no selective disadvantage is
associated with the SNPs.
PSEN expression in the developing porcine brain
PSEN1 and PSEN2 have been shown to be widely
expressed during embryonic development and especially
the expression profile in the CNS is well characterized [25-
27]. Here, we measured the mRNA expression levels of
PSEN1 and PSEN2 in hippocampus, cerebellum, frontal
cortex, basal ganglia, and brain stem from dissected por-
cine foetus brains at days 60, 80, 100 and 114 of gestation
using three biological samples for each of the time points.
Multiple amino acid sequence alignment of PSEN2Figure 2
Multiple amino acid sequence alignment of PSEN2. The alignment was performed using Clustal W. The sequences are Sus scrofa 
(DQ853415), Bos taurus (NM 174440), Homo sapiens (NM 000447), and Mus musculus (NM 011183). An asterisk (*) indicates 
conserved amino acids among the sequences, whereas amino acid discrepancies are marked in bold. Above the sequence align-
ments are by (+) indicated the position of pathogenic missense mutations identified in human PSEN2. Also the position of a 
human missense SNP is indicated above the sequence alignments with the alternative amino acid in bold. Furthermore, the 9 
transmembrane domains are depicted in cyan according to the transmembrane prediction programme HMMTOP [33], 
whereas amino acid discrepancies are marked in bold.Page 4 of 11
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PCR analyses were performed in triplicates. The require-
ment for a proper internal control gene was met by nor-
malization to the GAPDH expression level to compensate
for inter-PCR variation with respect to RNA integrity and
sample loading. We did not find any significant variation
in expression of GAPDH within the 5 different porcine
brain tissues at the various developmental stages. The
standard curve for the control GAPDH (R2 = 0.98), PSEN1
(R2 = 0.98), and PSEN2 (R2 = 0.98) were generated by
plotting Ct values versus log µL of cDNA. The slope of the
regression line was used to calculate the amount of cDNA
and thus mRNA in each sample. All GAPDH cDNA's gen-
erated almost identical Ct values within each type of tissue
(data not shown) and accordingly the mRNA expression
levels of PSEN1 and PSEN2 were normalized to the
GAPDH expression level. Ethidium bromide-staining
after real time PCR confirmed specific amplification of the
relevant PCR products (data not shown).
PSEN1 and PSEN2 were expressed in all 5 tissues at the 4
time points evaluated. However, it should be noted, that
for both PSEN1 and PSEN2 the mean standard deviation
is considerable, reflecting a high heterogeneity among
animals. In basal ganglia the PSEN1 expression levels did
not vary significantly between the different times of gesta-
tion (Figure 3). In frontal cortex, cerebellum, and hippoc-
ampus the PSEN1 expression level was significantly lower
at day 114 of gestation compared to day 60 (P = 0.001, P
= 0.036, and P = 0.003, respectively), yielding a reduction
of 5, 2, and 3 times for these tissues (Figure 3). Further-
more, the reduction in PSEN1 expression in frontal cortex
is also significant at day 80 compared to day 60 (P =
0.003). Similarly, PSEN1 expression is gradually reduced
in hippocampus during the time period of gestation (Fig-
ure 3). Moreover, the same tendency is seen in cerebel-
lum, however the reduction in expression levels is only
significant between day 100 and 114 (P = 0.015) and day
60 and 114 (P = 0.036).
Table 2: Genotype-frequencies for three SNPs in PSEN1 intron 
10 (DQ86246) in a pig breed-panel
Breed No. of 
animals
Genotype frequencies
SNP position 1535/1575 SNP position 1600
C/C T/T C/T G/G A/A G/A
Landrace 14 0.71 0 0.29 1 0 0
Duroc 14 0.57 0.07 0.36 1 0 0
Hampshire 11 0 1 0 1 0 0
Yorkshire 16 0.63 0 0.37 0.69 0 0.31
Analysis of porcine PSEN1 and PSEN2 expression levels in the developing pig brain by quantitative real-time RT-PCRFigure 3
Analysis of porcine PSEN1 and PSEN2 expression levels in 
the developing pig brain by quantitative real-time RT-PCR. 
Quantitative results are presented as normalized mean (± 
SD). For quantification and statistical analysis see materials 
and methods section. Each sample was run both in three bio-
logical and three technical triplicates. The expression analysis 
was performed on samples from frontal cortex, cerebellum, 
hippocampus, basal ganglia, and brain stem derived from 
embryonic days 60, 80, 100, and 114 (E60, E80, E100, and 
E114).
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Table 1: Genotype-frequencies of a C/T SNP in position 1163 
(DQ86246) in PSEN1 intron 8 in a pig breed-panel
Breed No. of 
animals
Genotype frequencies
SNP position 1163
C/C T/T C/T
Landrace 14 0 0.71 0.29
Duroc 15 0 0.60 0.40
Hampshire 17 1 0 0
Yorkshire 14 0 0.62 0.38Page 5 of 11
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frontal cortex. In hippocampus the only significant varia-
tion was seen as an increase in expression level between
day 60 and 80 of gestation (P = 0.015) (Figure 3). Also in
the brain stem, PSEN2 is upregulated between day 60 and
80 of gestation (P = 0.032) (Figure 3). In cerebellum and
basal ganglia the expression levels of PSEN2 are up-regu-
lated between day 80 and 100 (P = 0.003, and P = 0.03)
(Figure 3). In conclusion, the real time PCR analysis
showed significant, but small, alterations in the expres-
sion levels of PSEN1 and PSEN2 mRNA in different brain
compartments during embryonic brain development,
which likely reflect biological importance. Furthermore,
Western blotting (Figure 4) showed only minor differ-
ences in the levels of PS1 and PS2 in the frontal cortex
between various time points, which generally agree well
with the real time PCR measurements of expression. Both
antibodies used in the present study have been used pre-
viously in Western blots to detect PS1 and PS2 in human
and mouse homogenates [28,29]. Figure 4A and 4B show
that both antibodies detected a band at ≈ 47 kDa, repre-
senting the full-length proteins. The bands located below
the 47 kDa suggest that porcine PSENs are subject to pro-
teolytic processing as observed in other species.
To examine the localization of the PSEN1 and PSEN2 pro-
teins in situ we utilized immunohistochemical stainings at
embryonic day 100 brain slides with antibodies for
PSEN1 and PSEN2. PSEN1 staining was more intense and
had a more diffuse staining pattern outside cell bodies
than observed for the PSEN2 staining (Figure 5). We note
that all PSEN2 stained regions also were positive for
PSEN1 staining (Figure 5). Similar localization or inten-
sity of PSEN1 and PSEN2 staining were detected in analy-
sis of other embryonic time points or brain regions (data
not shown). Intracellular immunostaining was confined
to the cytoplasm with a distinct sparing of the nuclei. The
immunostaining was observed in all parts of the CNS,
especially in neurons but also to some extend in astrocytes
(Figure 5 and data not shown). In cortex both pyramidal
and nonpyramidal cells were stained (Figure 4). Also, all
hippocampus CA subfields and the granule cells were
PSEN positive (Figure 5). The immunohistochemical
analysis supports that the PSEN proteins are located in the
majority, if not all, of the neurons. Moreover, all PSEN2
stained cell types were also positive for PSEN1 staining in
accordance with the observed redundancies in PSEN1 and
PSEN2 functions [11,12].
Discussion
Here we describe the isolation and primary characteriza-
tion of PSEN1 and PSEN2 from pigs. Thus, chromosomal
mapping assigned the porcine PSEN1 and PSEN2 to
SSC7q12-q23 and SSC10p11-p16, respectively, which is
in accordance with the known syntenic relationships with
human chromosomes 14 and 1 [24]. Pig PSEN1 and
PSEN2 have protein sequences that are highly homolo-
gous to the human counterparts. Conservation included
the two catalytic aspartic acid residues located in adjacent
transmembrane domains, the C-terminal "PAL" sequence
involved in defining the catalytic active site conformation,
all of the nine transmembrane domains, and the C-termi-
nal part. The evolutionary conservation of these amino
acid segments strongly advocate that they are essential for
PSEN functions [1]. For instance, the aspartate residues
are critical for PSEN1 endoproteolysis and γ-secretase
activity, leading to the hypothesis that the proteolytic
cleavage generating the N- and C-terminal PSEN frag-
ments is an autocatalytic event necessary for activation of
PSEN, and that PSENs are the intrinsic catalytic subunits
for γ-secretase aspartyl protease activity [21]. Furthermore,
non-conservative mutations within the invariant PAL
sequence abolish PSEN1 endoproteolysis and γ-secretase
activity, indicating that this sequence is crucial for the
enzymatic activity [20]. Approximately, 150 mutations in
human PSEN1 and ten mutations in human PSEN2 have
been associated with early onset Alzheimer's disease [18].
We observed complete identity between pig and human
PSENs of amino acid residues, which have been mutated
in Alzheimer's patients. This identity extends to the mouse
and cow PSENs, which underscores the functional impor-
tance of these residues, and further supports the notion
that the pig PSENs share the biological functions of other
mammalian PSENs.
Western blot detection of presenilin 1 and presenilin 2 in frontal cortex at vari us time of embryo ic d v lopmentFigure 4
Western blot detection of presenilin 1 and presenilin 2 in 
frontal cortex at various time of embryonic development. A: 
analysis of presenilin 1 using PS1 520 antibody in frontal cor-
tex at embryonic day 60, 80, 100 and 114. Full length preseni-
lin 1 is detected around 47 kDa. B: analysis of presenilin 2 
using PS2 APS 26 antibody in frontal cortex at embryonic day 
60, 80, 100 and 114. Full length presenilin 2 is detected 
around 47 kDa.
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BMC Neuroscience 2007, 8:72 http://www.biomedcentral.com/1471-2202/8/72We did not find any SNP's in exons 5, 7, 8 or 9, which are
hotspots for mutations causing familiar Alzheimer's dis-
ease. However, one SNP was found in intron 8 and three
others in intron 9. The allele frequencies of these SNPs dif-
fered markedly between Hampshire and the other porcine
breeds, possibly reflecting the different origins of these
breeds. SNPs are amenable to high-throughput analysis
and, therefore, an attractive type of DNA marker for ani-
mal identification, paternity testing, and genome scans for
QTL and disease genes.
Expression profiling showed a distinct spatiotemporal
regulation of PSEN transcription in various brain regions
at embryonic days 60, 80, 100, and 114. Thus, variation in
gene expression was observed for PSEN1 in frontal cortex,
cerebellum and hippocampus, whereas PSEN1 expression
in basal ganglia and brainstem did not vary significantly
between the different embryonic stages. The variation
pointed towards a reduction in PSEN1 expression
between day 60 and day 114 of gestation. Also, PSEN2
showed differential expression during the gestation
period in some of the tested tissues. The variation in
expression levels suggests that both PSEN1 and PSEN2
play specific functions during embryonic brain develop-
ment. In this context, it is noteworthy that mice lacking
PSEN1 die shortly after birth and show a thinner ventricu-
lar zone, and substantial degeneration of the subcortical
region of the temporal lobe at embryonic day 14.5 and
16.5 [6]. In comparison, PSEN2 deficient mice show no
alterations in brain anatomy, and only with increasing age
developed mild pulmonary fibrosis [7]. However, mice
deficient in both PSEN1 and PSEN2 display early embry-
onic patterning defects resulting in lethality (before E9.5)
[11]. This suggests that PSEN2 is capable of performing
some PSEN1 functions in early developmental stages, and
that PSEN1 largely can substitute for PSEN2 functions
during development. Our immunohistochemical analysis
showed that at the protein level PSEN2 are expressed in
the same cells in the CNS as PSEN1 and that the PSENs
localize mainly in neuronal cell types but also in astro-
cytes. Such localizations were in accordance with human,
mouse and, rat brain studies [25,26]. Taken together, the
expression data support the notion that redundancy of
PSEN1 and PSEN2 functions during development might
be attributed to both the high degree of sequence similar-
ity and the consistent expression of PSEN2 in cells also
expressing PSEN1.
Conclusion
Our data show that the pig PSENS are conserved both at
the primary sequence level and in patterns of gene expres-
sion during embryonic brain development. Since pigs
share many physiologic and anatomic characteristics with
humans, this makes them interesting and attractive mod-
els for developmental studies [30]. The here presented ini-
Immunohistochemical analysis of PSEN1 and PSEN2 expression in embryonic E100 porcine brainsFigure 5
Immunohistochemical analysis of PSEN1 and PSEN2 expression 
in embryonic E100 porcine brains. Coronal brain sections 
were immunohistochemical stained for PSEN1 or PSEN2 and 
nuclei counterstained by haematoxylin. Sections illustrating 
PSEN2 (left sections) and PSEN1 (right sections) staining pat-
terns in hippocampus (A), cerebral cortex (B), and cerebellar 
cortex (C) are shown for embryonic day E100. The upper sec-
tions in panel A, B and C were magnified ×20 and the lower 
sections ×160. The regions enlarged in the lower sections are 
approximately indicated by the squares in the upper sections. 
The enlarged region in panel A corresponds to hippocampal 
pyramidal neurons (PN) of the CA3. The hippocampal dentate 
gyrus (DG) is indicated in the upper sections. The enlarged 
region in panel B corresponds to cortical neurons (CN) of the 
cerebral cortex. The enlarged region in panel C shows the 
molecular layer (ML), Purkinje neurons (PN), and the granular 
cell layer (GCL) of the cerebellar cortex.Page 7 of 11
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BMC Neuroscience 2007, 8:72 http://www.biomedcentral.com/1471-2202/8/72tial characterization of the porcine PSENs could be the
first step towards a future inclusion of the pig as a model
animal to study and elucidate the biological functions of
the PSENs.
Methods
PSEN1 and PSEN2 Isolation and sequencing
Pig brain, lymphocyte, and liver RNA was isolated with
the TRI-reagent (Sigma). For RT-PCR of PSEN1 the follow-
ing primers were used (PSEN1forward, 5'-TGGAGGA-
GAACACATGAAAGAAAG-3'; PSEN1-forward-EcoR1 5'-
GGGGAATTCTGGAGGAGAACACATGAAAGAAAG-3';
PSEN1reverseEcoR1, 5'-GGGGAATTCCCTGACTTTGTTA-
GATGTGGACAC-3'). The RT-PCR reaction was incubated
at 50°C for 60 min with the reverse primer followed by
PCR with the PSEN1forward-EcoR1 and PSEN1reverse-
EcoR1 primers at conditions (94°C for 3 min, 35 cycles of;
94°C, 45 sec; 62°C, 30 sec; 68°C, 2 min, followed by a
final elongation step at 68°C for 7 min). Amplified DNA
fragments were purified from agarose gels and either
directly sequenced or EcoR1 cloned into pCDNA3 fol-
lowed by DNA purification and sequencing. For RT-PCR
of PSEN2 the following primers were used (PSEN2-for-
ward, 5'-GCCATGCTCACTTTCATGGC-3'; PSEN2-reverse,
5'-CACGACTGCGTCCAGTGACC-3'). The reverse tran-
scription reaction was accomplished using the Invitrogen
reverse transcription system (Invitrogen) and 5 µg of total-
RNA according to the manufacturer's instructions. Subse-
quently, the PCR reaction was carried out at the following
conditions: (94°C for 3 min, 35 cycles of; 94°C, 45 sec;
60°C, 30 sec; 68°C, 2 min, followed by a final elongation
step at 68°C for 7 min). Amplified DNA fragments were
purified from agarose gels and either directly sequenced
or cloned into pCR® 2.1-TOPO® Vector (Invitrogen) fol-
lowed by DNA purification and sequencing. The porcine
pSEN1 and pSEN2 cDNA sequences were submitted to
GenBank (Accession numbers DQ853416, and
DQ853415, respectively)
BAC-hybridisation
Radioactive probes were generated employing the nick
translation kit from Invitrogen which incorporated [α-
32P]dCTP into the PCR generated PSEN1-exon8 fragment.
High-density colony BAC filters (a generous gift from Dr.
P. D. Jong) of the porcine genome were screened with the
PSEN1-exon8 probe. The filters were pre-hybridized,
hybridized, washed and autoradiographed according to
standard methods. Positive spots were localised and BAC
DNA of positive clones was isolated using the alkaline
lysis method described by Zhang et al. (1996). BAC clone
388G9 contained the PSEN1 genomic sequence and was
used for intronic sequence generation.
Generation of intron sequence information
The BAC clone 388G9 was sequenced with primers
located in exons 5, 7, 8 and 9 and pointing towards the
intronic sequences. Table 3 shows the applied primers. All
exon and flanking intronic sequences were deposited as a
gapped submission to GenBank (Accession number
DQ86246).
SNP screening
Exons 5, 7, 8 and 9 and flanking intron sequences were
amplified by PCR (primers listed in table 3 under SNP-
screening application). Exon 5 and flanking intron
sequences were amplified at conditions 50 ng DNA; 94°C
for 3 min and 35 cycles; 94°C, 30 sec; 60°C, 20 sec; 72°C,
1 min. Exon 7 and flanking intron sequences were ampli-
fied at conditions 50 ng DNA; 94°C for 3 min and 35
cycles; 94°C, 20 sec; 58°C, 20 sec; 72°C, 1 min. Exon 8
and flanking intron sequences were amplified at condi-
tions 50 ng DNA; 94°C for 3 min and 35 cycles; 94°C, 45
sec; 64°C, 30 sec; 72°C, 1 min. Exon 9 and the flanking
intron sequences were amplified at conditions 50 ng
DNA; 94°C for 3 min and 35 cycles; 94°C, 20 sec; 58°C,
20 sec; 72°C, 1 min. All PCR products were incubated
with exozap at 37°C for 1 hour and sequenced with the
forward amplification primer. The sequences were ana-
lyzed using PolyBace and checked manually in Consed.
Hybrid cell mapping
A porcine-rodent somatic cell hybrid panel was used for
physical mapping (Yerle et al., 1996) of both PSEN1 and
PSEN2. For PSEN1 the exon 9 forward and reverse primers
2 were used for amplification of the probe fragment. For
PSEN2 the PCR primers (PSEN2exon12F; 5'-GTTTGT-
GTCTGACCCTCCTGCTGC-3' and PSEN2exon12R; 5'-
CAGATGTAGAGCTGGTGGGGAGG-3') were used for
amplification of the probe fragment. PCR's were per-
formed in a total volume of 10 µL containing 10 ng DNA,
1 × PCR buffer, 2.5 mM of each dNTP, 5 pmol of each
primer, and 0.5 U of Taq polymerase (Bioline) under the
following conditions: 94°C for 3 min; 35 cycles of 94°C
for 20 s, 65°C for 20 s and 72°C for 20 s, and a final elon-
gation step for 5 min at 72°C.
Immunohistochemistry
Fetal pig brains were immersion fixed in formalin and
paraffin-embedded tissue blocks were produced from var-
ious brain regions. 10 µm coronal sections were then
obtained on coated glass slides. The sections were depar-
affinized and pretreated with proteinase K for 6 min. The
slides were blocked with BSA (1 mg/ml) for 10 min.
Immunohistochemical demonstration of PSEN1 and
PSEN2 was performed using the EnVision+ System-HRP-
DAB (DAKO). The anti-PSEN1 antibody derived from
human was a rabbit polyclonal antiserum 520 (a gener-
ous gift from Dr. Paul Fraser, Toronto, Canada) used inPage 8 of 11
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PSEN2 antibody derived from human was the mouse
monoclonal antibody, APS 26, used in 1:33 dilution
with 2 hours incubation time (abcam). Nuclei were
counterstained in haematoxylen solution. The slides
were finally coverslipped with Faramount Aqueous
Mounting Medium (DAKO).
Western Blotting
200 mg frontal cortex from embryonic day 60, 80, 100,
and 114 of gestation were homogenized mechanically
in 1 mL extraction buffer, pH 8.3 (50 mM Tris, 10 mM
EDTA, and complete protease inhibitor (Roche, Penz-
berg, Germany)). Subsequently, 1 mL extraction buffer
was further added and 500 µL treatment buffer, pH 6.8
(0.125 M Tris, 4 % SDS, 20 % glycerol) was added to
500 µL of the cleared tissue lysate. The samples were
incubated at 50°C for 25 min following protein quanti-
fication by BCA protein assay kit (Pierce, Rockford, IL).
20 µg total protein from each sample were heated to
95°C for 10 min in the treatment buffer before being
separated on a 15 % Tris-HCl gel (Bio-Rad, Hercules,
CA). The membranes were blocked with 5% skim milk
powder in 0.05% TBST buffer and incubated overnight
with anti-PSEN1 rabbit polyclonal antiserum diluted
1:250 and mouse monoclonal anti-PSEN2, APS 26,
diluted 1:1000. Bound primary antibodies were
detected by binding with horseradish peroxidase-conju-
gated anti-rabbit IgG or polyclonal anti-mouse second-
ary antibodies, both diluted 1:2000 (Dako, Glostrup,
Denmark). The blots were visualized with BM Chemilu-
minescence blotting substrate according to manufac-
tures instructions (Roche, Penzberg, Germany).
Real-time quantitative PCR assay
Total RNA was isolated from cerebellum, frontal cortex,
hippocampus, brainstem, and basal ganglia from 60,
80, 100, and 114 days old porcine fetuses using the TRI
Reagent™ (Sigma) in compliance with the manufac-
turer's instructions. Three separate tissues were applied
for each type of tissue and time in gestation, yielding a
total of 60 samples. The reverse transcription reaction
was accomplished using an Invitrogen reverse transcrip-
tion system (Invitrogen) and 5 µg of RNA according to
the manufacturer's instructions. Quantitative real time
PCR was performed using the TaqMan® assay and PCR
amplification in an ABI-PE prism 7900 sequence detec-
tion system (PE Applied Biosystems). Primers and MGB
probes were designed using the Primer Express Software
2.0 (PE Applied Biosystems), so that both forward and
reverse primer spanned an exon-exon junction. The
MGB probe was synthesized with VIC as a reporter dye.
After an initial screening with different control genes
GAPDH was chosen as the endogenous control and the
MGB-probe was synthesized with VIC as a reporter dye.
Table 3: Sequences of primers and real time PCR probes
Primer and probes Sequence Application
PS1 Exon 5 forward 
primer1
5'-
GGAGGTGGTAATGTG
GTTGG-3'
BAC sequencing
PS1 Exon 5 reverse 
primer1
5'-
CCAACCATAAGAAGAA
CTGGG-3'
BAC sequencing
PS1 Exon 7 forward 
primer1
5'-
CCTATAACGTTGCCAT
GGATTAC-3'
BAC sequencing
PS1 exon 7 reverse 
primer1
5'-
CACAGCCAAGATGAG
CCAC-3'
BAC sequencing
PS1 Exon 8 forward 
primer1
5'-
GCTGGTTGAAACAGCT
CAGGAG-3'
BAC sequencing
PS1 Exon 8 reverse 
primer1
5'-
CCAGCAAACGAAGTG
GGCCATTTG-3'
BAC sequencing
PS1 Exon 9 forward 
primer1
5'-
CAACAATGGTGTGGTT
GGTG-3'
BAC sequencing
PS1 Exon 9 reverse 
primer1
5'-
GGATACCTTCCTTTGG
GCTTC-3'
BAC sequencing
PS1 Exon 5 forward 
primer2
5'-
GACACTTACCTGGGG
CTTTGTG-3'
SNP screening
PS1 Exon 5 reverse 
primer2
5'-
CCAAGTAAGGTGAGA
CAGGAAAACC-3'
SNP screening
PS1 Exon 7 forward 
primer2
5'-
GCTACGAGTATGAAGG
TGGGATATG-3'
SNP screening
PS1 exon 7 reverse 
primer2
5'-
CCAGGAGTCAAGATAA
CTGG-3'
SNP screening
PS1 Exon 8 forward 
primer2
5'-
CCACCATCTGTTTACC
TGCTA-3'
SNP screening
PS1 Exon 8 reverse 
primer2
5'-
GGCCATCATTACATGT
GTTTG-3'
SNP screening
PS1 Exon 9 forward 
primer2
5'-
GGTGACATTAAGAAGT
TTGGTGACTTG-3'
SNP screening
PS1 Exon 9 reverse 
primer2
5'-
GGGTGTTACCACAGCT
TGGAG-3'
SNP screening
PS1 forward primer 5'-
GTGATTTCAGTATACG
ATTTAGTGGCTG-3'
Real Time PCR
PS1 reverse primer 5'-
CACCAACCACACCATT
GTTGAC-3'
Real Time PCR
PS1 MGB probe 5'-VIC-
TTGTGTCCAAATGGC-
3'
Real Time PCR
PS2 forward primer 5'-
GGAGGAAAGGGGCGT
GAAG-3'
Real Time PCR
PS2 reverse primer 5'-
CACAAACCGATGAGG
ATGGC-3'
Real Time PCR
PS2 MGB probe 5'-VIC-
CTGGAACACCACGCT
GG-3'
Real Time PCR
GAPDH forward 
primer
5'-
GACTCATGACCACGGT
CCATG-3'
Real Time PCR
GAPDH reverse 
primer
5'-
GTCAGATCCACAACCG
ACACG-3'
Real Time PCR
GAPDH MGB probe 5'-VIC-
CATCACTGCCACCCAG
A-3'
Real Time PCRPage 9 of 11
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mixtures for PSEN1, PSEN2, and GAPDH were prepared
and consisted of 5 µL 2× TaqMan® Universal PCR Master
Mix, 0.3 µL of each primer (10 µM), 0.25 µL probe (5
µM), 2 µL of a 5-fold diluted cDNA template, and H2O to
a final volume of 10 µL. Real-time PCR was done under
the following conditions: 2 min at 50°C, 10 min at 95°C,
40 cycles of 95°C for 15 sec and 60°C for 1 min. For both
PSEN1, PSEN2, and GAPDH PCRs were performed in trip-
licate. The cycle threshold (Ct) values corresponding to
the PCR cycle number at which fluorescence emission in
real time reaches a threshold above baseline emission
were determined in SDS 2.2 (PE Applied Biosystems). To
compare expression patterns in the various brain tissues at
different developmental stages mRNA template concen-
trations for GAPDH, PSEN1, and PSEN2 were calculated
using the standard curve method. Standard curves were
constructed using 8 fold dilution of day 114 frontal cortex
cDNA (4, 2, 1, 0.5, 0.25, 0.125, and 0.0625 µL). The
mRNA quantity of each amplicon was calculated for each
standard and experimental sample.
Statistical analysis
The equality of PSEN1 and PSEN2 expression levels
between different time of gestation within the 5 sampled
tissues were tested for statistical significance using the
standalone software REST© [31]. The statistical model
applied was the Pair Wise Fixed Reallocation Randomisa-
tion Test. The assumption regarding normal distribution
of the data was avoided, and differences in expression
between groups were assessed using the means for statisti-
cal significance by randomization. The level of probability
was set at P < 0.05 as statistically significant and 50000
randomization steps were implemented in each compari-
son.
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